Comparison of occurrence rate of stent restenosis following sirolimus-eluting and paclitaxel-eluting stent implantation

    loading  Checking for direct PDF access through Ovid

Abstract

Percutaneous transluminal coronary angioplasty (PTCA) is a key means in treating coronary atherosclerotic heart disease, however, the main problem of which is restenosis following stent implantation. Stents carrying sirolimus and paclitaxel are the main drug-eluting stents, which can dramatically decrease the occurrence rate of restenosis. Especially sirolimus-eluting stents, which had superior characteristics to paclitaxel-eluting stents in preventing coronary restenosis, and decreasing of target lesion revascularization. With development of research, there will be satisfactory answers to restenosis following stent implantation.

Related Topics

    loading  Loading Related Articles